Key result
Captopril improves endothelial function in a hamster HF model by normalizing NOSIII and reducing superoxide.
Why the study?
Mechanisms underlying increased oxidative stress in vascular tissue in chronic congestive heart failure were not fully understood.
Does captopril reduce oxidative stress and improve NO signaling in an experimental model of chronic congestive heart failure?
Does captopril reduce oxidative stress and improve NO signaling in an experimental model of chronic congestive heart failure?
ACE inhibition with captopril reduces oxidative stress and improves endothelial function in a hamster model of heart failure by preventing NOSIII uncoupling.
Supports ACE inhibition on endothelial function in experimental HF; leaves open human translation.
OBJECTIVE: In the present study, we sought to identify mechanisms underlying increased oxidative stress in vascular tissue in an experimental animal model of chronic congestive heart failure (CHF). METHODS AND RESULTS: Superoxide and nitric oxide (NO) was measured in vessels from cardiomyopathic hamsters (CHF hamsters) and golden Syrian hamsters. We also determined expression of endothelial nitric oxide synthase (NOSIII), the soluble guanylyl cyclase, the cGMP-dependent kinase, and the NADPH oxidase. To analyze the contribution of the renin-angiotensin system to oxidative stress, CHF hamsters were treated with the angiotensin-converting enzyme inhibitor captopril for 200 days (120 mg . kg(-1) . d(-1)). CHF led to increased superoxide production by NOSIII and the NADPH oxidase. Decreased NO production in CHF was associated with a decrease in the expression of NOSIII and an inhibition of NO downstream signaling in the aorta. NOSIII expression was increased within the left ventricle. Captopril treatment normalized NOSIII expression in vessels and the myocardium, reduced superoxide levels, and prevented NOSIII uncoupling. Accordingly, endothelial function, NO production, and downstream signaling were improved in CHF vessels. CONCLUSIONS: Oxidative stress in CHF is mediated by NADPH oxidase and an uncoupled NOSIII secondary to an activation of the renin-angiotensin system leading to impaired NO downstream signaling.
No takes yet. Share an insight, caveat, or question.
Mollnau et al. (2005) studied Chronic congestive heart failure (CHF). Captopril vs. Untreated CHF hamsters / Golden Syrian hamsters was evaluated on Superoxide and nitric oxide (NO) production, NOSIII expression, and endothelial function. Captopril treatment (120 mg/kg/d for 200 days) normalized NOSIII expression, reduced superoxide levels, and improved endothelial function in an experimental hamster model of heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: